Business · 30/01/2020
FDA Announces Final Guidance for Human Gene Therapy INDs
The FDA has released a final guidance document outlining recommendations for sponsors of human gene therapy Investigational New Drug Applications (INDs) to provide sufficient Chemistry, Manufacturing, and Control (CMC) information to ensure product safety and quality.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →